alpha-ketoisovalerate has been researched along with creatine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Almeida, LM; Funchal, C; Gottfried, C; Pessoa-Pureur, R; Wajner, M | 1 |
Funchal, C; Gottfried, C; Jacques-Silva, MC; Pessoa-Pureur, R; Santos, AQ; Schuck, PF; Wajner, M | 1 |
2 other study(ies) available for alpha-ketoisovalerate and creatine
Article | Year |
---|---|
Evidence that the branched-chain alpha-keto acids accumulating in maple syrup urine disease induce morphological alterations and death in cultured astrocytes from rat cerebral cortex.
Topics: Actins; Animals; Animals, Newborn; Astrocytes; Brain; Cell Death; Cell Shape; Cells, Cultured; Cerebral Cortex; Creatine; Creatine Kinase; Cytoskeleton; Dose-Response Relationship, Drug; Energy Metabolism; Enzyme Inhibitors; Glial Fibrillary Acidic Protein; Hemiterpenes; Keto Acids; Lysophospholipids; Maple Syrup Urine Disease; Rats; Rats, Wistar; rhoA GTP-Binding Protein | 2004 |
Creatine and antioxidant treatment prevent the inhibition of creatine kinase activity and the morphological alterations of C6 glioma cells induced by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.
Topics: Animals; Antioxidants; Cell Line, Tumor; Cell Shape; Creatine; Creatine Kinase; Glioma; Hemiterpenes; Humans; Keto Acids; Maple Syrup Urine Disease; Rats | 2006 |